Healthcare & Life Sciences
MediLink Therapeutics
aliveseries-b
series-b
Stage
2020
Founded
2
Investors
About
The startup develops conjugated drugs using its proprietary ADC technology.
Explore MediLink Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.